Bleomycin pharmacology in relation to adverse effects and renal function in cervical cancer patients
- 1 December 1982
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 14 (3) , 350-354
- https://doi.org/10.1016/0090-8258(82)90109-3
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Bleomycin-mitomycin C therapy for advanced squamous carcinoma of the cervixGynecologic Oncology, 1980
- Effectiveness of a sequential combination of bleomycin and mitomycin-C on an advanced cervical cancerCancer, 1978
- Bleomycin pharmacokinetics in manCancer Chemotherapy and Pharmacology, 1978
- Clinical pharmacology of bleomycin following intravenous infusion as determined by radioimmunoassayCancer, 1977
- Guidelines for Drug Therapy in Renal FailureAnnals of Internal Medicine, 1977
- Bleomycin serum pharmacokinetics as determined by a radioimmunoassay and a microbiologic assay in a patient with compromised renal functionCancer, 1977
- Low dose bleomycin and methotrexate in cervical cancerCancer, 1976
- Clinical PharmacokineticsNew England Journal of Medicine, 1975
- Clinical PharmacokineticsNew England Journal of Medicine, 1975
- Combination chemotherapy with bleomycin and methotrexate in recurrent and disseminated cervical carcinoma: A preliminary studyGynecologic Oncology, 1973